Translate
MEDIA CONTACT
Press Release
March 14, 2023 at 5:00 pm
< 1 minute read

NOTICE OF CCRC BOARD MEETING


Please be advised that the next Capital City Redevelopment Corporation Board Meeting will be held in person and via teleconference on Tuesday, March 21, 2023, at 11:00 am. 

Members of the public who wish to speak during the public comment segment of the meeting, pertaining to agenda items, may attend in person or call into the meeting by using the conference number, and are encouraged to call in prior to the meeting start time to avoid any delays.

IN PERSON:

NJEDA Board Room

36 West State Street, Trenton, NJ 08625

TELECONFERENCE:

CONFERENCE NAME:                                CCRC BOARD MEETING

PARTICIPANT DIAL-IN NUMBER:              551-220-2262

PARTICIPANT ACCESS CODE:                    621 124 85#

The agenda can be found 48 hours prior to the meeting at our website: www.njeda.gov/ccrc.

SHARE

Related Content

Press Release

July 28, 2026

NJEDA Updates RETROFIT NJ Program, Increasing Funding and Paving Way for Second Phase of Program

TRENTON, N.J. (July 28, 2026) – Last week, the New Jersey Economic Development Authority (NJEDA) Board approved modifications to the Reducing Emissions through Retrofits, Optimization, Fuel-Switching, and Innovative Technologies (RETROFIT NJ) Grant Program to expand available funding and advance more solar generation, battery storage, and thermal energy network (TEN) projects.

Press Release

July 24, 2026

NJEDA Approves CAFE Program Awards for Projects in Westfield and Millburn

TRENTON, N.J. (July 24, 2026) – The New Jersey Economic Development Authority (NJEDA) Board approved two awards under the Cultural Arts Facilities Expansion (CAFE) Program, paving the way for projects at the Center for Creativity at the Rialto in Westfield and the Paper Mill Playhouse in Millburn.

Press Release

July 23, 2026

Oncology Therapies Manufacturer Approved for NJEDA Next New Jersey Manufacturing Award

TRENTON, N.J. (July 23, 2026) – The New Jersey Economic Development Authority (NJEDA) Board approved a Next New Jersey Manufacturing Program award for Hopewell-based BeOne Medicines US Manufacturing Co., Inc.